<video controls preload=”metadata” width=”100%” style=”border-radius:16px;”>
<source src=”https://markets-headlines.com/wp-content/uploads/2025/12/Aleen-Inc-CSE-ALEN-U-1-1.mp4″ type=”video/mp4″>
Your browser does not support the video tag.
</video>

Equity Insider News Commentary

Issued on Behalf of Aleen Inc. 

VANCOUVER, BC –  Equity Insider  — A global AI infrastructure transformation is underway as next-generation models move from concept to real-world deployment. Last month, Google’s launch of Gemini 3 demonstrated that advanced AI systems can now exceed human performance on complex cognitive tasks[1]. In parallel, international regulators accelerated the adoption of strict medical-device AI frameworks[2], signaling that the technology is ready for commercial integration across healthcare.

This rapid shift from research environments to market-scale implementation is creating a new competitive landscape for specialized operators, including Aleen Inc., Moderna, GE HealthCare, CeriBell, and Palantir Technologies.

Market Summary

The AI-in-healthcare market is projected to reach $505.59 billion by 2033 as adoption accelerates[3]. Workforce transformation is also expanding, with companies such as Accenture shifting more than 800,000 employees toward AI-integrated workflows[4].

Stats

  • AI in Healthcare Market (2033): $505.59 billion
  • Global Digital Wellness Market (2034): $45.65 billion
  • Consumer Adoption: ~57% using digital well-being tracking
  • Workforce AI Transition: 800,000+ employees retrained at Accenture
  • Aleen Funding Target: $20–$30 million strategic investment

Companies in Focus

Aleen Inc. (CSE: ALEN-U)
Aleen Inc., a Canadian digital wellness company, continues developing AI tools designed for personal reflection and self-awareness—not medical diagnosis. Its Wellness AI platform helps users observe daily habits, identify behavioral patterns, and reflect on personal well-being.

“Our goal is to help people observe themselves with clarity,” said Oleksandr Luzin, Director of Aleen Inc. “Wellness AI is not about diagnosis — it is about reflection, insight, and discovering what your own patterns can teach you.”

Aleen is also developing a personal account ecosystem that will allow users to upload, manage, and visualize non-medical well-being data.

“Our focus is on how an analytical tool can responsibly support everyday wellness — while staying entirely outside diagnostic or medical functions,” said Anastasiia Kalashnik, PR Specialist.

Moderna, Inc.
Moderna projected up to 10% revenue growth by 2026 and continues advancing its oncology and vaccine portfolios.

GE HealthCare
GE HealthCare and Mayo Clinic launched GEMINI-RT to integrate imaging, AI, and monitoring to personalize radiation therapy.

CeriBell, Inc.
CeriBell secured FDA clearance for the first AI EEG seizure-detection tool covering pre-term neonates through adults.

Palantir Technologies Inc.
Palantir partnered with Multiverse to support NHS adoption of the Federated Data Platform, enabling major operational gains.

Read our full article:

AI Engine Replaces The Waiting Room: Powering The $660B Health Revolution

Read Our Full Disclaimer

https://equity-insider.com/disclaimer/

Media Contacts

Equity Insider
info@equity-insider.com
(604) 265-2873